Melanoma Foundation of New England Company Profile

04:46 EDT 24th September 2017 | BioPortfolio

News Articles [1853 Associated News Articles listed on BioPortfolio]

Brigham and Women's Hospital's Department of Dermatology and Six Flags New England Partner with the Melanoma Foundation of New England in the Fight against Tanning

CONCORD, Mass., Feb. 7, 2012 /PRNewswire-USNewswire/ -- The second most common cancer among teens and young adults 15-29 is melanoma, the deadliest form of skin cancer. It's no coincidence that...

Early Stage Melanoma Identified by Simple Blood Test

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes....

Link established between a molecular driver of melanoma, novel therapeutic agent

Scientists have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful infor...

CMA clears Birmingham hospitals merger

The Competition and Markets Authority has cleared a merger between Heart of England NHS Foundation Trust (HEFT) and University Hospitals Birmingham NHS Foundation Trust (UHB).

Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma

(European Society for Medical Oncology) Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage III BRAF-mutant melanoma, according to...

CNIO researcher funded by Melanoma Research Alliance to study brain metastasis in melanoma

(Centro Nacional de Investigaciones Oncológicas (CNIO)) Manuel Valiente, head of the Brain Metastasis Group at the Spanish National Cancer Research Centre (CNIO), has been funded in the 2017 grant cy...

Adjuvant nivolumab superior to ipilimumab in surgically resected stage III/IV melanoma

(European Society for Medical Oncology) Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage III/IV melanoma who are at high risk of relapse, accord...

Link established between a molecular driver of melanoma & novel therapeutic agent

(The Wistar Institute) Wistar scientists have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced me...

Drugs and Medications [472 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [2708 Associated PubMed Articles listed on BioPortfolio]

The academic foundation programme: a new foundation for academic medicine.

Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.

To explore health-related quality of life (HRQoL) in recurrence-free melanoma patients, with a focus on the association between melanoma-related limb lymphoedema and HRQoL.

Contemporary Management of Early-Stage Melanoma: A Systematic Review.

The incidence of melanoma is increasing, with 76 380 new cases of invasive melanoma and 68 480 new cases of melanoma in situ expected in 2016.

Melanoma of the Foot.

Palmar melanoma: A tertiary centre experience.

Acral melanoma is the most common subtype of melanoma in darker-pigmented individuals, and recent studies report that acral melanoma shows unique behaviours compared to other subtypes.(1) Previous rep...

Clinical Trials [1287 Associated Clinical Trials listed on BioPortfolio]

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Participants with advanced or metastatic mucosal melanoma (cohort A) and acral lentiginous melanoma (cohort B) eligible for treatment with nivolumab in combination with ipilimumab followed...

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. It is not yet known whether combining melanoma vaccine with interleukin-2 is more effective than vaccine...

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

The purpose of this study is to examine the health behaviors of melanoma survivors. We want to know about their thoughts and concerns. Melanoma is a type of skin cancer. The number of peop...

Vaccination Plus Ontak in Patients With Metastatic Melanoma

The purpose of this study is to determine if an experimental melanoma vaccine can produce an immune response in patients with metastatic melanoma, and if combining this vaccine with the d...

Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients

This phase I/II study is directed at evaluating safety and immunogenicity of a melanoma peptide vaccine in combination or not with Dacarbazine administration in melanoma patients

Companies [1606 Associated Companies listed on BioPortfolio]

AIM at Melanoma

AIM at Melanoma, founded in memory of Charlie Guild, who died of melanoma at the age of 26, is the largest international melanoma foundation focused on melanoma research, patient ...

Melanoma Foundation of New England

Polynoma LLC

Malignant melanoma is the most serious form of skin cancer. An estimated 200,000 new cases of melanoma are diagnosed annually around the world, with about 76,000 in the United Sta...

Melanoma Research Foundation

Mollie Biggane Melanoma Foundation

More Information about "Melanoma Foundation of New England" on BioPortfolio

We have published hundreds of Melanoma Foundation of New England news stories on BioPortfolio along with dozens of Melanoma Foundation of New England Clinical Trials and PubMed Articles about Melanoma Foundation of New England for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Melanoma Foundation of New England Companies in our database. You can also find out about relevant Melanoma Foundation of New England Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record